Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Combination of Anti-CD123 and Anti-CD19 Chimeric Antigen Receptor T Cells for the Treatment and Prevention of Antigen-Loss Relapses Occurring after CD19-Targeted Immunotherapies

Marco Ruella, MD, David M. Barrett, MD PhD, Saad S Kenderian, MD, Olga Shestova, PhD, Ted J. Hofmann, PhD, John Scholler, Simon F. Lacey, PhD BSc, J. Joseph Melenhorst, PhD, Farzana Nazimuddin, Jessica Perazzelli, PhD, David A Christian, PhD, Christopher A Hunter, PhD, David L Porter, MD, Carl H. June, MD, Stephan A. Grupp, MD PhD, Saar I Gill, MBBS, PhD

Blood (2015) 126 (23): 2523.

https://doi.org/10.1182/blood.V126.23.2523.2523

Published: 2015

Journal Articles

Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin

José Villagra, Sruti Shiva, Lori A. Hunter, Roberto F. Machado, Mark T. Gladwin, Gregory J. Kato

Blood (2007) 110 (6): 2166–2172.

https://doi.org/10.1182/blood-2006-12-061697

Published: 2007

Includes: Supplemental data

Journal Articles

Platelet Activation Is Linked to the Severity of Pulmonary Hypertension in Sickle Cell Disease and Normalizes on Sildenafil Therapy.

Jose D. Villagra, MD, Roberto F. Machado, MD, Lori A. Hunter, RN, Mark T. Gladwin, MD, Gregory J. Kato, MD

Blood (2005) 106 (11): 3166.

https://doi.org/10.1182/blood.V106.11.3166.3166

Published: 2005

Journal Articles

The Sickle Cell-Pulmonary Hypertension Screening Study: ECHO Findings at Two-Years of Follow Up.

Oswaldo Castro, MD, Gregory Kato, MD, Vandana Sachdev, MD, Roberto Machado, MD, Inez Ernst, RN, Wynona A. Coles, RRT, James S. Nichols, RN, Lori A. Hunter, RN, Mark T. Gladwin, MD

Blood (2005) 106 (11): 314.

https://doi.org/10.1182/blood.V106.11.314.314

Published: 2005

Journal Articles

Allogeneic Stem Cell Transplantation Using a Reduced Intensity Conditioning (RIC) Regimen Has the Capacity To Produce Durable Remissions and Long Term Disease-Free Survival in Patients with High Risk Acute Myeloid Leukemia (AML).

Blood (2005) 106 (11): 1141.

https://doi.org/10.1182/blood.V106.11.1141.1141

Published: 2005

Journal Articles

Impact of In Vivo T-Cell Depletion on Outcome Following Reduced Intensity Transplantation for Hodgkin Lymphoma: Comparison between 2 Prospective Studies.

K. S. Peggs, A. Sureda, A. Hunter, M. D. Caballero, J. Cavet, A. Urbano-Ispizua, A. Parker, J. M. Ribera, P. Mahendra, M. A. Canales, D. Milligan, J. C. Hernandez-Boluda, E. C. Morris, I. Alvarez, A. H. Goldstone, D. C. Linch, J. Sierra, S. Mackinnon

Blood (2004) 104 (11): 807.

https://doi.org/10.1182/blood.V104.11.807.807

Published: 2004

Journal Articles

Pulmonary Hypertension in Sickle Cell Disease: Cardiopulmonary Evaluation and Response to Chronic Phosphodiesterase 5 Inhibitor Therapy.

Roberto F. Machado, MD, Sabrina E. Martyr, BS, Anastasia Anthi, MD, Gregory J. Kato, MD, Lori A. Hunter, RN, Wynona A. Coles, RRT, James S. Nichols, RN, Oswaldo L. Castro, MD, Mark T. Gladwin, MD

Blood (2004) 104 (11): 235.

https://doi.org/10.1182/blood.V104.11.235.235

Published: 2004

Journal Articles

Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) [see comments]

N Schmitz, P Dreger, M Suttorp, EB Rohwedder, T Haferlach, H Loffler, A Hunter, NH Russell

Blood (1995) 85 (6): 1666–1672.

https://doi.org/10.1182/blood.V85.6.1666.bloodjournal8561666

Published: 1995

Journal Articles

Risk factors for acute graft-versus-host disease associated with cyclosporine and methotrexate prophylaxis [letter; comment]

N Russell, S Rogers, A Hunter

Blood (1993) 81 (7): 1972–1974.

https://doi.org/10.1182/blood.V81.7.1972.1972

Published: 1993

NARROW

Combination of Anti-CD123 and Anti-CD19 Chimeric Antigen Receptor T Cells for the Treatment and Prevention of Antigen-Loss Relapses Occurring after CD19-Targeted Immunotherapies

Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin

Platelet Activation Is Linked to the Severity of Pulmonary Hypertension in Sickle Cell Disease and Normalizes on Sildenafil Therapy.

The Sickle Cell-Pulmonary Hypertension Screening Study: ECHO Findings at Two-Years of Follow Up.

Allogeneic Stem Cell Transplantation Using a Reduced Intensity Conditioning (RIC) Regimen Has the Capacity To Produce Durable Remissions and Long Term Disease-Free Survival in Patients with High Risk Acute Myeloid Leukemia (AML).

Impact of In Vivo T-Cell Depletion on Outcome Following Reduced Intensity Transplantation for Hodgkin Lymphoma: Comparison between 2 Prospective Studies.

Pulmonary Hypertension in Sickle Cell Disease: Cardiopulmonary Evaluation and Response to Chronic Phosphodiesterase 5 Inhibitor Therapy.

Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) [see comments]

Risk factors for acute graft-versus-host disease associated with cyclosporine and methotrexate prophylaxis [letter; comment]

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only